Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer. (Q37834921)
Jump to navigation
Jump to search
scientific article published on April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer. |
scientific article published on April 2011 |
Statements
Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer (English)
Neal Ready
Nina A Karaseva
Alexander V Luft
Olexandr Popovych
Jon T Holmlund
Brian A Wood